Assertio Therapeutics, Inc. buy PlusUltra
Start price
13.03.20
/
50%
€0.71
Target price
22.05.20
€3.00
Performance (%)
2.13%
End price
22.05.20
-
Summary
This prediction ended on 22.05.20 with a price of -. With a performance of 2.13%, the BUY prediction by PlusUltra for Assertio Therapeutics, Inc. closed with a slight gain. PlusUltra has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Assertio Therapeutics, Inc. | -2.667% | -2.667% | -87.813% | -92.074% |
| iShares Core DAX® | -1.283% | 4.209% | 7.084% | 64.252% |
| iShares Nasdaq 100 | -3.338% | -1.744% | 26.177% | 84.969% |
| iShares Nikkei 225® | -4.286% | -1.621% | 44.320% | 79.253% |
| iShares S&P 500 | -2.311% | -0.096% | 20.823% | 68.079% |
Comments by PlusUltra for this prediction
In the thread Discuss Assertio Therapeutics, Inc.
Buy with target price 3.0